Primary |
Cardiac Failure Congestive |
22.2% |
Atrial Fibrillation |
11.1% |
Atrial Flutter |
11.1% |
Constipation |
11.1% |
Epilepsy |
11.1% |
Essential Hypertension |
11.1% |
Pneumonia Bacterial |
11.1% |
Sleep Disorder |
11.1% |
|
|
Secondary |
Product Used For Unknown Indication |
42.2% |
Ill-defined Disorder |
10.9% |
Constipation |
9.7% |
Infection |
5.5% |
Drug Use For Unknown Indication |
3.7% |
Insomnia |
3.5% |
Pyrexia |
3.5% |
Wound Complication |
2.9% |
Convulsion Prophylaxis |
2.6% |
Cerebral Infarction |
2.3% |
Schizophrenia |
2.0% |
Pain |
1.8% |
Hypertension |
1.4% |
Gastritis |
1.3% |
Fluid Replacement |
1.3% |
Parkinson's Disease |
1.3% |
Prophylaxis |
1.3% |
Bipolar Disorder |
1.2% |
Neurogenic Bladder |
1.0% |
Anxiety Disorder |
0.9% |
|
Drug Rash With Eosinophilia And Systemic Symptoms |
28.8% |
Stevens-johnson Syndrome |
9.1% |
Drug Reaction With Eosinophilia And Systemic Symptoms |
7.6% |
Abortion Induced |
6.1% |
Sepsis |
6.1% |
Vomiting |
6.1% |
Pyrexia |
4.5% |
Deafness Neurosensory |
3.0% |
Drug Exposure During Pregnancy |
3.0% |
Eosinophil Count Increased |
3.0% |
Haemoptysis |
3.0% |
Lymphocyte Stimulation Test Positive |
3.0% |
Pancreatitis |
3.0% |
Urticaria |
3.0% |
Vanishing Bile Duct Syndrome |
3.0% |
Cardio-respiratory Arrest |
1.5% |
Colonic Polyp |
1.5% |
Completed Suicide |
1.5% |
Erythema Multiforme |
1.5% |
Hallucination |
1.5% |
|
Concomitant |
Prophylaxis |
20.0% |
Constipation |
16.2% |
Product Used For Unknown Indication |
12.8% |
Drug Use For Unknown Indication |
8.2% |
Pain |
5.7% |
Hypertension |
5.6% |
Insomnia |
4.9% |
Cancer Pain |
4.2% |
Multiple Myeloma |
3.4% |
Schizophrenia |
2.9% |
Nausea |
2.3% |
Gastritis |
2.0% |
Diabetes Mellitus |
1.9% |
Cardiac Failure |
1.7% |
Depression |
1.6% |
Back Pain |
1.5% |
Rheumatoid Arthritis |
1.5% |
Nutritional Support |
1.2% |
Pneumonia |
1.2% |
Premedication |
1.2% |
|
White Blood Cell Count Decreased |
15.1% |
Pyrexia |
9.0% |
Vomiting |
8.4% |
Pneumonia |
6.0% |
Intestinal Obstruction |
5.8% |
White Blood Cell Count Increased |
5.1% |
Thrombocytopenia |
4.6% |
Interstitial Lung Disease |
4.4% |
Somnolence |
4.4% |
Rash |
4.2% |
Renal Failure |
3.9% |
Hepatic Function Abnormal |
3.7% |
Stomatitis |
3.7% |
Malaise |
3.5% |
Suicide Attempt |
3.5% |
Nausea |
3.2% |
Hepatic Encephalopathy |
3.0% |
Pneumonia Aspiration |
2.8% |
Urine Output Decreased |
2.8% |
Wrong Technique In Drug Usage Process |
2.8% |
|
Interacting |
Product Used For Unknown Indication |
38.0% |
Asthma |
12.0% |
Constipation |
12.0% |
Hypertension |
12.0% |
Bronchitis |
6.0% |
Gastric Ulcer |
6.0% |
Trigeminal Neuralgia |
6.0% |
Depression |
4.0% |
Onychomycosis |
2.0% |
Psychotic Disorder |
2.0% |
|
Therapeutic Response Decreased |
60.0% |
Dementia |
20.0% |
Urosepsis |
20.0% |
|